Pathologic Features of Anti-Mi-2 Dermatomyositis

Tanboon, J; Inoue, M; Hirakawa, S; Tachimori, H; Hayashi, S; Noguchi, S; Suzuki, S; Okiyama, N; Fujimoto, M; Nishino, I

Nishino, I (corresponding author), Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo, Japan.; Nishino, I (corresponding author), Natl Ctr Neurol & Psychiat, Dept Genome Med Dev, Med Genome Ctr, Kodaira, Tokyo, Japan.; Nishino, I (corresponding author), Natl Ctr Neurol & Psychiat, Clin Genome Anal, Med Genome Ctr, Kodaira, Tokyo, Japan.

NEUROLOGY, 2021; 96 (3): E448

Abstract

Objective To identify the characteristic pathologic features of dermatomyositis (DM) associated with anti-Mi-2 autoantibodies (anti-Mi-2 DM). Methods ......

Full Text Link